Premalignant gastric lesions in patients with gastric mucosa-associated lymphoid tissue lymphoma and metachronous gastric adenocarcinoma
Authors:
- Lisette G. CapelleLCLisette G. Capelle
- Caroline M. Den HoedCHCaroline M. Den Hoed
- Annemarie C. de VriesAVAnnemarie C. de Vries
- Katharina BiermannKBKatharina Biermann
- Mariel K. CasparieMCMariel K. Casparie
- Gerrit A. MeijerGMGerrit A. Meijer
- Ernst J. KuipersEKErnst J. Kuipers
- 1 January 2012
- journal article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 24 (1) , 42-47
Abstract
Patients with gastric mucosa-associated lymphoid tissue lymphoma or diffuse large B-cell lymphoma have an increased risk of developing gastric carcinoma (GC). Identifying patients at high GC risk may lead to improved survival and prognosis. The aim of this case-control study was to evaluate whether premalignant gastric lesions are more prevalent and severe in gastric lymphoma (GL) patients with a subsequent diagnosis of GC than in those without GC. Patients with a first GL diagnosis from 1991-2008 were identified in the Dutch histopathology registry (PALGA). Cases were patients with a diagnosis of GL and a subsequent diagnosis of GC. Controls were patients with a diagnosis of GL without GC development. In total, eight cases (mean follow-up 5.5 years) and 31 controls (mean follow-up 5.3 years) were included (mean age 60 years). At lymphoma diagnosis, six (75%) cases were diagnosed with premalignant lesions, whereas in the control group, 21 (68%) had histological evidence for premalignant lesions (P=0.69). At GC diagnosis, five (63%) cases showed intestinal metaplasia in the surrounding gastric mucosa. In 22 (71%) controls premalignant lesions were present at the end of follow-up (P=0.47). No differences were demonstrated in the prevalence of premalignant lesions of cases and controls at GL diagnosis or the end of follow-up. As the prevalence of premalignant lesions is substantial in both the groups of patients, careful endoscopic surveillance of GL patients is warranted not only for recurrence of lymphoma, but also for progression to adenocarcinoma.Keywords
This publication has 31 references indexed in Scilit:
- Gastric MALT lymphoma: Epidemiology and high adenocarcinoma risk in a nation-wide studyEuropean Journal of Cancer, 2008
- Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and managementAnnals of Oncology, 2008
- Gastric Cancer Risk in Patients With Premalignant Gastric Lesions: A Nationwide Cohort Study in the NetherlandsGastroenterology, 2008
- Epidemiology of Premalignant Gastric Lesions: Implications for the Development of Screening and Surveillance StrategiesHelicobacter, 2007
- Frequent and Rapid Progression of Atrophy and Intestinal Metaplasia in Gastric Mucosa of Patients with MALT LymphomaAmerican Journal of Gastroenterology, 2006
- Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infectionGastroenterology, 2001
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001
- Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomasAmerican Journal of Gastroenterology, 2001
- Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pyloriThe Lancet, 1993
- Helicobacter pylori-associated gastritis and primary B-cell gastric lymphomaThe Lancet, 1991